MRVI

Maravai LifeSciences Holdings, Inc.

MRVI · CIK 1823239 · Annual (10-K) · Last 5 years

Financial Trends

Revenue$186M
20212025
Net Income−$131M
20212025
Operating CF−$58M
20212025
Free Cash Flow−$71M
20212025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue$0.2B$0.3B$0.3B$0.9B$0.8B
Cost of Revenue$0.2B$0.2B$0.1B$0.2B$0.1B
Gross Profit$0.0B————
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.1B$0.2B$0.2B$0.1B$0.1B
Operating Income$-0.2B$-0.2B$-0.0B$0.6B$0.6B
Net Income$-0.1B$-0.1B$-0.1B$0.2B$0.2B
EPS (Basic)$-0.90$-1.05$-0.90$1.67$1.59
EPS (Diluted)$-0.90$-1.05$-0.90$1.67$1.56

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.8B$1.0B$1.5B$2.3B$1.9B
Current Assets$0.3B$0.4B$0.7B$0.8B$0.7B
Cash & Equivalents$0.2B$0.3B$0.6B$0.6B$0.6B
Total Liabilities$0.4B$0.4B$0.7B$1.4B$1.4B
Current Liabilities$0.0B$0.1B$0.1B$0.1B$0.1B
Stockholders' Equity$0.2B$0.3B$0.4B$0.5B$0.3B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.1B$0.0B$0.1B$0.5B$0.4B
Investing Cash Flow$-0.0B$-0.0B$-0.1B$-0.3B$0.1B
Capital Expenditures$0.0B$0.0B$0.1B$0.0B$0.0B
Financing Cash Flow$-0.0B$-0.2B$-0.1B$-0.2B$-0.2B
← Companies